Skip to main content

Sign up for our newsletter.

Quality journalism. Progressive values. Direct to your inbox.

Pfizer's headquarters

People walk by the Pfizer world headquarters in New York on November 9, 2020. (Photo: Kena Betancur/AFP via Getty Images)

Insulated From Patent Waivers, Pfizer and Moderna Hike Vaccine Prices

"Capitalism never fails to not surprise," wrote one observer.

Julia Conley

With some of the world's wealthiest countries continuing to oppose temporary patent waivers for Covid-19 vaccines in order to more rapidly deploy life-saving shots worldwide, pharmaceutical giants Pfizer and Moderna have raised the price for European Union orders.
 
In its new supply contract with the E.U., Pfizer named a price of more than $23 per dose, up nearly 25% from about $18 on earlier purchases. Moderna said in its latest agreement that its mRNA vaccine will cost one-tenth more than its previous price, charging $25.50 per dose.

"Our governments are complicit in this heist by pharma and companies across the board in other sectors. It's the system they helped create."
—Tahir Amin, intellectual property lawyer

 
The two companies plan to provide the E.U. with 2.1 billion vaccine doses until 2023, and are already expected to rake in tens of billions of dollars this year from vaccine sales.
 
"Capitalism never fails to not surprise," tweeted The New Yorker writer John Cassidy in response to reporting from the Financial Times.
 
With patent protections kept in place by the World Trade Organization (WTO) as E.U. countries including Germany, Switzerland, and the United Kingdom oppose lifting Trade-Related Aspects of Intellectual Property Rights (TRIPS) for Covid-19-related products, vaccine doses have mainly been available in wealthy countries. 
 
According to the New York Times' latest analysis, 0.3% of doses have been administered in low-income countries, leading public health experts to warn that Covid-19 will continue to mutate and dangerous, highly infectious variants like Delta will continue to emerge and spread throughout the world.
 
The companies are raising their prices "just in time for the Delta variant," one observer wrote on Twitter.
 
Pfizer and Moderna have raised their prices as Europe faces supply chain issues with the Johnson & Johnson and AstraZeneca vaccines—the latter of which has been more widely available in low-income countries—and as new studies showed higher efficacy of the mRNA vaccines compared to the cheaper shots.
 
An official involved in the price negotiations told the Financial Times that Pfizer and Moderna used the "usual pharma rhetoric" in discussing the price hikes.
 
"Vaccines work so they increased the 'value,'" the official said.
 
With the two companies continuing to sell most of its supply to high-income countries, Pfizer's sales are now expected to reach $56 billion and Moderna's are expected to reach $30 billion. 
 
"E.U., care to rethink your position on a patent waiver?," tweeted Nick Dearden, director of Global Justice Now, which has been calling for the WTO to lift patent protections for Covid-19 vaccines for months.
 
Intellectual property lawyer Tahir Amin wrote on social media that lifting patent protections for vaccines, as South African and Indian WTO representatives first proposed last year, would suspend the tool "that enables and supports this monopoly" controlled by Big Pharma.
 
"Our governments are complicit in this heist by pharma and companies across the board in other sectors," Amin said.

Our work is licensed under Creative Commons (CC BY-NC-ND 3.0). Feel free to republish and share widely.

We've had enough. The 1% own and operate the corporate media. They are doing everything they can to defend the status quo, squash dissent and protect the wealthy and the powerful. The Common Dreams media model is different. We cover the news that matters to the 99%. Our mission? To inform. To inspire. To ignite change for the common good. How? Nonprofit. Independent. Reader-supported. Free to read. Free to republish. Free to share. With no advertising. No paywalls. No selling of your data. Thousands of small donations fund our newsroom and allow us to continue publishing. Can you chip in? We can't do it without you. Thank you.

Scientist Says Some Coral Reefs Can Be Saved 'If We Take Immediate Action'

"People need to be aware this is coming up fast, and the time to explore mitigation techniques is now," warns another researcher behind a recently published study.

Jessica Corbett ·


Ro Khanna Lays Out New Vision for American Manufacturing and Economic Progress

"Embracing a New Economic Patriotism plan isn't just about jobs. It's about unifying Americans—from the coasts to the heartland—with a shared purpose."

Brett Wilkins ·


Peace Groups Push US to Use 'All Points of Leverage' to End Saudi Blockade of Yemen

"The Biden administration must take urgent action to compel Saudi Arabia to completely lift this blockade as a humanitarian act, for the sake of millions of Yemenis in desperate need."

Jessica Corbett ·


Freelance Photographer Says He Was Fired by NYT Over Support for Palestinian Resistance

"What is taking place is a systematic effort to distort the image of Palestinian journalists as being incapable of trustworthiness and integrity, simply because we cover the human rights violations that the Palestinian people undergo on a daily basis at hands of the Israeli army."

Kenny Stancil ·


'Cruel Disregard for Life': Rights Groups Condemn Iran's Deadly Attacks on Protesters

Human Rights Watch documented lethal repression by government forces against protesters "in largely peaceful and often crowded settings, altogether killing and injuring hundreds."

Brett Wilkins ·

Common Dreams Logo